Moderate dose radiotherapy effective in EORTC trial for patients with desmoid-type fibromatosis

(European Organisation for Research and Treatment of Cancer) A phase 2 EORTC trial for patients with inoperable desmoid-type fibromatosis has shown that moderate dose radiotherapy is an effective treatment for patients with such a rare type of tumor. The study results published in Annals of Oncology show that response after radiation therapy is slow, and that continuing regression is seen even after three years.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news

Related Links:

Int J Clin Exp Pathol. 2021 Mar 1;14(3):355-362. eCollection 2021.ABSTRACTMetaplastic breast carcinoma is a rare invasive breast cancer. Metaplastic breast carcinoma is mainly characterized by an epithelial or mesenchymal cell population mixed with adenocarcinoma. We collected 26 cases of metaplastic breast carcinoma in the First Affiliated Hospital of Bengbu Medical College from 2008 to 2014. Tumor size, tumor grade, vascular invasion, ER/PR status, histologic classification, and HER2/neu status were assessed for all cases and the literature was reviewed. Clinicopathologic characteristics of patients diagnosed with metapl...
Source: International Journal of Clinical and Experimental Pathology - Category: Pathology Authors: Source Type: research
More News: Cancer | Cancer & Oncology | Fibroma | Health | International Medicine & Public Health | Radiation Therapy | Study